• Biosino Bio-Technology and Science shareholders will vote November 20, 2026, on appointing Pan Guangjin as an independent non-executive director, replacing Jin Tengchuan.
• Pan’s proposed term runs from shareholder approval until the current board’s term expires.
• Proposed articles amendments would specify Chinese accounting standards for financial statements, removing references to international or overseas standards.
• The amendments also add founding shareholders’ names and initial holdings; passage requires a special resolution.
• The board recommends voting in favor of all resolutions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosino Bio-Technology and Science Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261030-12389866), on October 30, 2026, and is solely responsible for the information contained therein.